Patents by Inventor Bernd Nederlof

Bernd Nederlof has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8557571
    Abstract: A reactor has a reactor unit with a first chamber and a second chamber, with the first chamber being formed by the interior of a housing and the second chamber being formed by the interior of a plurality of hollow fibers arranged in the housing. The hollow fibers are arranged in the housing such that their density in at least one region of the first chamber does not exceed 10 fibers/mm2, based on the cross-sectional area of the first chamber. The reactor unit can include two casting compounds, in which a portion of the hollow fibers are embedded and between which another portion of the hollow fibers extends. The length of at least some or all of the hollow fibers is at least 0.5% greater than the distance of the casting compounds.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: October 15, 2013
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Franz Kugelmann, Paul Hengster, Raimund Margreiter, Bernd Nederlof, Massimo Fini, Ciro Tetta, Thomas Wild, Micaela Yakubovich, Michael Paul, Marco Caronna
  • Publication number: 20080145926
    Abstract: This invention relates to a reactor unit with a first chamber and a second chamber, wherein the first chamber is formed by the interior of a housing and wherein the second chamber is formed by the interior of a plurality of hollow fibers arranged in the housing. The hollow fibers are arranged in the housing such that their density in at least one region of the first chamber does not exceed 10 fibers/mm2, based on the cross-sectional area of the first chamber. In accordance with another aspect of the invention it is provided that in the reactor unit two casting compounds are arranged, in which a portion of the hollow fibers is embedded and between which another portion of the hollow fibers extends, wherein the length of at least some or all hollow fibers is at least 0.5% greater than the distance of the casting compounds.
    Type: Application
    Filed: December 22, 2005
    Publication date: June 19, 2008
    Inventors: Franz Kugelmann, Paul Hengster, Raimund Margreiter, Bernd Nederlof, Massimo Fini, Ciro Tetta, Thomas Wild, Micaela Yakubovich, Michael Paul, Marco Caronna
  • Patent number: 5846419
    Abstract: A hemo(dia)filtration apparatus (10) is described comprising a dialyzer (12) and two sterile filters (38) and (60). The first chambers (42) and (64) of both sterile filters (38) and (60) may be switched at least intermittently during flow through, thereby flushing out membranes (40) and (62) of both sterile filters (38) and (60) and effectively preventing an accumulation of germs and pyrogens. This prevents an increase in the transmembrane pressure (TMP), which reduces the likelihood of a rupture, thereby ensuring sterility of the dialyzer fluid and improving the operating safety of the hemodiafiltration apparatus (10).
    Type: Grant
    Filed: July 10, 1997
    Date of Patent: December 8, 1998
    Assignee: Fresenius AG
    Inventor: Bernd Nederlof
  • Patent number: 5660722
    Abstract: Described is a hemo(dia)filtration apparatus (10) with two blood filters (60) and (12) connected in series and a sterile filter (38) connected upstream thereof. The first chambers (64) and (14) and the second chambers (68) and (16) of both blood filters (60) and (12) are connected to one another, respectively, by connecting lines (72) and (74). A means (76) is arranged in one of the connecting lines (72) and (74), which generates a positive transmembrane pressure in the direction of the blood path in one of the blood filters (60, 12) and a negative transmembrane pressure in the direction of the blood path (80) in the other blood filter (12, 60). This eliminates a costly substituate line with additional devices arranged therein, since the dialyzer fluid is passed as a substituate solution through the membrane of the one blood filter directly into the blood. Furthermore, with the use of suitable devices it is possible to precisely determine and individually adjust the filtrate and substituate flows.
    Type: Grant
    Filed: July 11, 1995
    Date of Patent: August 26, 1997
    Assignee: Fresenius AG
    Inventor: Bernd Nederlof